Cancer, Nutrition and Taste

Inclusion criteria

• Patient with advanced lung cancer requiring a first line of intravenous chemotherapy or patient with localized, histologically or cytologically proven breast cancer for whom intravenous chemotherapy treatment will be initiated or patient with stage III-IV gynecological cancer (ovarian cancer or uterine cancer) for whom intravenous chemotherapy treatment will be initiated.

• Patient with a body mass index (BMI) between 18Kg/m² and 35Kg/m².
• Patient whose indication for treatment with intravenous chemotherapy has been selected
• Naive patient of previous chemotherapy.
• Life expectancy > 3 months.
• Patient able to travel for 4 visits to the Paul Bocuse Institute, 1 Chemin de Calabert, 69 130 ECULLY, FRANCE.
• Written informed consent obtained in accordance with applicable GCPs.
• Patients affiliated to a social security system.
• Patients who have the possibility of being accompanied, by the same person, to the visits of the test meals at the Paul Bocuse Research Institute

Exclusion criteria

• Patient under 18 years of age.
• Patient who has had another malignant tumor in the last 3 years.
• Patient with symptomatic brain metastases.
• Patient with symptomatic mucositis.
• Patient suffering or having suffered from an otorhinolaryngic or oesogastrointestinal pathology interfering with food intake.
• Patients with digestive disorders before any cancer treatment.
• Indication for concomitant radiotherapy or immunotherapy alone treatment.
• Patient with a known food allergy or food intolerance.
• Patient with partial or total agueusia diagnosed.
• Patient with diagnosed partial or total anosmia.
• Patients who have used artificial feeding within 2 months.
• Patients who have lost more than 10% of their baseline weight within 2 months.
• Patient unable to be regularly monitored for any reason
• Patient deprived of liberty or placed under guardianship or curatorship
• Pregnant or breastfeeding patient.